Register Login
Register to leave comments
  • News bot May 7, 2026, 8:07 p.m.

    📋 BRIDGEBIO PHARMA, INC. (BBIO) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:02:53

    Event Type: Financial Results

    Event Details:

    BRIDGEBIO PHARMA, INC. (BBIO) Reports the reporting period Financial Results BRIDGEBIO PHARMA, INC. (BBIO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (2,379)
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 882018 Management Commentary: '"This was another strong quarter for Attruby, highlighting the continued durable growth trajectory for use in ATTR-CM by physicians compounding quarter over quarter," said Matt Outten'
      • expected in the second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Selling General Administrative 20.25K 18.00K $2.25K +12.51%
    Total Operating Expenses 300.47K 300.47K $0.00 +0.00%
    Cost Of Revenues Selling General Administrative 163.90K 106.36K $57.53K +54.09%
    Cost Of Revenues Total Operating Expenses 300.47K 221.00K $79.47K +35.96%
    Cost Of Revenues Loss From Operations -105.96K -104.37K $-1.58K -1.52%
    Other Income Expense Net Interest Income 6.25K 5.38K $861.00 +15.99%
    Other Income Expense Net Interest Expense -12.94K -18.12K $5.18K +28.58%
    Other Income Net 4.25K 8.23K $-3.98K -48.33%
    Net Loss -166.56K -169.61K $3.05K +1.80%
    Net Loss Attributable Noncontrolling 2.51K 2.19K $326.00 +14.91%
    Net Loss Attributable Common Stockholders -164.04K -164.04K $0.00 +0.00%
    Assets Cash Equivalents Marketable Securities 940.19K 940.19K $0.00 +0.00%
    Assets Prepaid Expenses Other Current Assets 62.91K 44.07K $18.84K +42.76%
    Assets Property Equipment Net 4.94K 5.37K $-425.00 -7.92%
    Assets Operating Lease Right Of Use Assets 17.23K 8.15K $9.08K +111.39%
    Assets Intangible Assets Net 27.36K 28.08K $-718.00 -2.56%
    Assets Other Assets 18.62K 16.71K $1.91K +11.42%
    Liabilities Redeemable Convertible Noncontrolling Interests And Stockholders Deficit Accounts Payable 29.06K 29.06K $0.00 +0.00%
    Liabilities Redeemable Convertible Noncontrolling Interests And Stockholders Deficit Operating Lease Liabilities 18.66K 10.00K $8.65K +86.49%
    Liabilities Redeemable Convertible Noncontrolling Interests And Stockholders Deficit Other Long Term Liabilities 229.00 244.00 $-15.00 -6.15%
    Liabilities Redeemable Convertible Noncontrolling Interests And Stockholders Deficit Redeemable Convertible Noncontrolling Interests -951.00 -570.00 $-381.00 -66.84%
    Liabilities Redeemable Convertible Noncontrolling Interests And Stockholders Deficit Noncontrolling Interests 10.44K 10.60K $-160.00 -1.51%
    Operating Activities Net Loss -166.56K -166.56K $0.00 +0.00%
    Changes In Operating Assets And Liabilities Prepaid Expenses Other Current Assets -18.84K -487.00 $-18.36K -3769.61%
    Changes In Operating Assets And Liabilities Other Assets -1.79K 1.59K $-3.38K -213.11%
    Changes In Operating Assets And Liabilities Accounts Payable -7.17K 17.57K $-24.74K -140.81%
    Changes In Operating Assets And Liabilities Operating Lease Liabilities -1.85K -1.47K $-382.00 -25.99%
    Cash and Marketable Securities 940.19K 940.19K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 62.91K 44.07K $18.84K +42.76%
    Property and Equipment, Net 4.94K 5.37K $-425.00 -7.92%
    Intangible Assets, Net 27.36K 28.08K $-718.00 -2.56%
    Other Assets 18.62K 16.71K $1.91K +11.42%
    Accounts Payable 29.06K 29.06K $0.00 +0.00%
    Operating Lease Liabilities 18.66K 10.00K $8.65K +86.49%
    Revenue 17.89K 20.27K $-2.38K -11.74%
    Notes 741.40K 740.89K $512.00 +0.07%
    Notes 547.48K 547.01K $468.00 +0.09%
    Redeemable Convertible Noncontrolling Interests -951.00 -570.00 $-381.00 -66.84%
    Noncontrolling Interests 10.44K 10.60K $-160.00 -1.51%
    Net Loss -166.56K -166.56K $0.00 +0.00%
    Interest Expense 39.87K 24.02K $15.85K +66.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BRIDGEBIO PHARMA, INC.
    • Ticker Symbol: BBIO

Search

News categories